KEELY COX: Open Payments
NPI 1952955502 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 29 payments from 8 companies in 2025. Trend: 2023 $814 · 2024 $879 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $402 |
| Teva Pharmaceuticals USA, Inc. | 2 | $186 |
| ARGENX US, INC. | 3 | $174 |
| PFIZER INC. | 2 | $140 |
| Genentech, Inc. | 1 | $52 |
| Alexion Pharmaceuticals, Inc. | 2 | $34 |
| EMD Serono, Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $18 |
Products named: AUSTEDO XR, BOTOX, VYVGART, QULIPTA, ZAVZPRET, UBRELVY, Ocrevus, ULTOMIRIS.
Industry payments across ID — which companies pay providers there.
